SMS PHARMACEUTICALS LTD.

Company Profile

SMS PHARMACEUTICALS LTD. had its IPO on under the ticker symbol SMSPHARMA.

The company operates in the Other sector and Other industry. SMS PHARMACEUTICALS LTD. has a staff strength of 1,356 employees.

Stock update

Shares of SMS PHARMACEUTICALS LTD. opened at ₹125.5 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹120.9 - ₹127.05, and closed at ₹123.15.

This is a -3.15% slip from the previous day's closing price.

A total volume of 6,060 shares were traded at the close of the day’s session.

In the last one week, shares of SMS PHARMACEUTICALS LTD. have slipped by -3.83%.

SMS PHARMACEUTICALS LTD.'s Key Ratios

SMS PHARMACEUTICALS LTD. has a market cap of ₹7.29 billion, indicating a price to book ratio of 1.5603 and a price to sales ratio of 1.7592.

In the last 12-months SMS PHARMACEUTICALS LTD.’s revenue was ₹4.23 billion with a gross profit of ₹1.34 billion and an EBITDA of ₹819.57 million. The EBITDA ratio measures SMS PHARMACEUTICALS LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, SMS PHARMACEUTICALS LTD.’s operating margin was 14.33% while its return on assets stood at 6.01% with a return of equity of 9.08%.

In Q4, SMS PHARMACEUTICALS LTD.’s quarterly earnings growth was a positive 11.1% while revenue growth was a positive 10.6%.

SMS PHARMACEUTICALS LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

23.6456

PEG

Its diluted EPS in the last 12-months stands at ₹3.788 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into SMS PHARMACEUTICALS LTD.’s profitability.

SMS PHARMACEUTICALS LTD. stock is trading at a EV to sales ratio of 2.3931 and a EV to EBITDA ratio of 24.5516. Its price to sales ratio in the trailing 12-months stood at 1.7592.

SMS PHARMACEUTICALS LTD. stock pays annual dividends of ₹0.25 per share, indicating a yield of 0.29% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

₹8.58 billion

Total Liabilities

₹2.33 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

0%

SMS PHARMACEUTICALS LTD. ended 2024 with ₹8.58 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹8.58 billion while shareholder equity stood at ₹4.53 billion.

SMS PHARMACEUTICALS LTD. ended 2024 with ₹0 in deferred long-term liabilities, ₹2.33 billion in other current liabilities, 84652000.00 in common stock, ₹4.45 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹4.73 million and cash and short-term investments were ₹5.61 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹1.32 billion.

SMS PHARMACEUTICALS LTD.’s total current assets stands at ₹3.87 billion while long-term investments were ₹0 and short-term investments were ₹886000.00. Its net receivables were ₹936.68 million compared to accounts payable of ₹991.63 million and inventory worth ₹2.62 billion.

In 2024, SMS PHARMACEUTICALS LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, SMS PHARMACEUTICALS LTD. paid ₹0 in dividends in 2024.

Other key metrics

Current Trading Price

₹123.15

52-Week High

₹106.7

52-Week Low

₹54.5

Analyst Target Price

₹

SMS PHARMACEUTICALS LTD. stock is currently trading at ₹123.15 per share. It touched a 52-week high of ₹106.7 and a 52-week low of ₹106.7. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹117.33 and 200-day moving average was ₹88.74 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 7302.2% of the company’s stock are held by insiders while 0% are held by institutions.